Lijun Wang1, Haitong Gu, Xinxin Lu. 1. Department of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, No1, Dongjiaominxiang Road, Dongcheng District, Beijing, 100730, China.
Abstract
BACKGROUND: Klebsiella pneumonia carbapenemases (KPCs) are able to hydrolyze the carbapenems, which cause many bacteria resistance to multiple classes of antibiotics, so the rapid dissemination of KPCs is worrisome. Laboratory identification of KPCs-harboring clinical isolates would be a key to limit the spread of the bacteria. This study would evaluate a rapid low-cost real-time PCR assay to detect KPCs. METHODS: Real-time PCR assay based on SYBR GreenIwas designed to amplify a 106 bp product of the blaKPC gene from the 159 clinical Gram-negative isolates resistant to several classes of -lactam antibiotics through antimicrobial susceptibility testing. We confirmed the results of real-time PCR assay by the conventional PCR-sequencing. At the same time, KPCs of these clinical isolates were detected by the modified Hodge test (MHT). Then we compared the results of real-time PCR assay with those of MHT from the sensitivity and specificity. Moreover, we evaluated the sensitivity of the real-time PCR assay. RESULTS: The sensitivity and specificity of the results of the real-time PCR assay compared with those of MHT was 29/29(100%) and 130/130(100%), respectively. The results of the real-time PCR and the MHT were strongly consistent (Exact Sig. (2-tailed) =1. 000; McNemar test). The real-time PCR detection limit was about 0.8 cfu using clinical isolates. CONCLUSION: The real-time PCR assay could rapidly and accurately detect KPCs -harboring strains with high analytical sensitivity and specificity.
BACKGROUND:Klebsiella pneumonia carbapenemases (KPCs) are able to hydrolyze the carbapenems, which cause many bacteria resistance to multiple classes of antibiotics, so the rapid dissemination of KPCs is worrisome. Laboratory identification of KPCs-harboring clinical isolates would be a key to limit the spread of the bacteria. This study would evaluate a rapid low-cost real-time PCR assay to detect KPCs. METHODS: Real-time PCR assay based on SYBR GreenIwas designed to amplify a 106 bp product of the blaKPC gene from the 159 clinical Gram-negative isolates resistant to several classes of -lactam antibiotics through antimicrobial susceptibility testing. We confirmed the results of real-time PCR assay by the conventional PCR-sequencing. At the same time, KPCs of these clinical isolates were detected by the modified Hodge test (MHT). Then we compared the results of real-time PCR assay with those of MHT from the sensitivity and specificity. Moreover, we evaluated the sensitivity of the real-time PCR assay. RESULTS: The sensitivity and specificity of the results of the real-time PCR assay compared with those of MHT was 29/29(100%) and 130/130(100%), respectively. The results of the real-time PCR and the MHT were strongly consistent (Exact Sig. (2-tailed) =1. 000; McNemar test). The real-time PCR detection limit was about 0.8 cfu using clinical isolates. CONCLUSION: The real-time PCR assay could rapidly and accurately detect KPCs -harboring strains with high analytical sensitivity and specificity.
Authors: Maria Virginia Villegas; Karen Lolans; Adriana Correa; Juan Nicolas Kattan; Jaime A Lopez; John P Quinn Journal: Antimicrob Agents Chemother Date: 2007-01-29 Impact factor: 5.191
Authors: Hesna Yigit; Anne Marie Queenan; J Kamile Rasheed; James W Biddle; Antonio Domenech-Sanchez; Sebastian Alberti; Karen Bush; Fred C Tenover Journal: Antimicrob Agents Chemother Date: 2003-12 Impact factor: 5.191
Authors: K F Anderson; D R Lonsway; J K Rasheed; J Biddle; B Jensen; L K McDougal; R B Carey; A Thompson; S Stocker; B Limbago; J B Patel Journal: J Clin Microbiol Date: 2007-06-20 Impact factor: 5.948
Authors: Fred C Tenover; Rajinder K Kalsi; Portia P Williams; Roberta B Carey; Sheila Stocker; David Lonsway; J Kamile Rasheed; James W Biddle; John E McGowan; Bruce Hanna Journal: Emerg Infect Dis Date: 2006-08 Impact factor: 6.883
Authors: H M Abdallah; B B Wintermans; E A Reuland; A Koek; N al Naiemi; A M Ammar; A A Mohamed; C M J E Vandenbroucke-Grauls Journal: PLoS One Date: 2015-05-22 Impact factor: 3.240
Authors: H M Abdallah; N Alnaiemi; E A Reuland; B B Wintermans; A Koek; A M Abdelwahab; A Samy; K W Abdelsalam; C M J E Vandenbroucke-Grauls Journal: Antimicrob Resist Infect Control Date: 2017-06-13 Impact factor: 4.887
Authors: H M Abdallah; E A Reuland; B B Wintermans; N Al Naiemi; A Koek; A M Abdelwahab; A M Ammar; A A Mohamed; C M J E Vandenbroucke-Grauls Journal: PLoS One Date: 2015-08-18 Impact factor: 3.240